Abstract
The relationship of ascorbic acid to cancer has, unfortunately, been one of some confusion. While there have been clinical reports suggesting that high doses of ascorbic acid (vitamin C) can exert an inhibitory effect on the development of cancer, these reports have not been adequately corroborated. Furthermore, the scientific literature on experimental animal studies and cell culture studies has offered only occasional suggestions that vitamin C has an anticancer effect. In fact, some of the experimental studies suggest that vitamin C may even have an enhancing effect on carcinogenesis and on subsequent developing cancers.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alcain, F. J., Buron, I. M., Rodriguez-Aguilera, J. C, Villalba, J. M., and Navaas, P, 1990, Ascorbate free radical stimulates the growth of a human promyelocytic leukemia cell line, Cancer Res. 50:5887–5891.
Banic, S., 1981, Vitamin C acts as a cocarcinogen to methylcholanthrene in guinea pigs, Cancer Lett. 11:239–242.
Benedict, W. F., Wheatlet, W. L., and Jones, P. A., 1980, Inhibition of chemically induced morphologic transformation and reversion of the transformed phenotype by ascorbic acid in C3H/10T1/2 cells, Cancer Res. 40:2796–2801.
Cameron, E., and Pauling, L., 1973, Ascorbic acid and the glycosaminoglycans: An orthomolecular approach to cancer and other diseases, Oncology 27:181–192.
Cameron, E., and Pauling, L., 1974, The orthomolecular treatment of cancer. 1. The role of ascorbic acid in host resistance, Chem. Biol. Interact. 9:273–283.
Cameron, E., and Pauling, L., 1976, Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer, Proc. Natl. Acad. Sci. USA 73:3685–3689.
Cameron, E., and Pauling, L., 1978, Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer, Proc. Natl. Acad. Sci. USA 75:4538–4542.
Cameron, E., Campbell, A., and Jack, T, 1975, The orthomolecular treatment of cancer. III. Reticulum cell sarcoma: Double complete regression induced by high-dose ascorbic acid therapy, Chem. Biol. Interact. 11:387–383.
Creagen, E. T., Moertel, C. G., O’Fallon, R., Schutt, A. J., O’Connell, M. J., Rubin, J., and Frytak, S., 1979, Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer: A controlled trial, N. Engl. J. Med. 301:687–690.
Dykes, M. H. M., and Meier, P., 1975, Ascorbic acid and the common cold—evaluation of its efficacy and toxicity, J. Am. Med. Assoc. 231:1073–1079.
Fukushima, S., Kurata, Y., Hasegawa, R., Asamoto, M., Shibata, M. A., and Tamano, S., 1991, L-Ascorbate acid amplification of bladder carcinogenesis promotion by K2C03, Cancer Res. 51:2548–2551.
Gimenez-Conti, I. B., and Slaga, T., 1993, The hamster cheek pouch carcinogenesis model, J. Cell. Biochem. 17F:83–90.
Golumbic, C, and Mattill, H. A., 1941, Antioxidants and the autoxidants of fats. XIII. The antioxigenic action of ascorbic acid in association with tocopherols, hydroquinones, and related compounds, J. Am. Chem. Soc. 63:1279–1280.
Hoflfer, A., and Pauling, L., 1990, Hardin Jones biostatistical analysis of mortality data for cohorts of cancer patients with a large fraction surviving at the termination of the study and a comparison of survival times of cancer patients receiving large regular oral doses of vitamin C and other nutrients with similar patients not receiving those doses, J. Orthomol. Med. 5:143-154.
Holtz, G., and Bresnick, E., 1988, Ascorbic acid inhibits the squamous metaplasia that results from treatment of tracheal expiants with asbestos or benzo(a)pyrene-coated asbestos, Cancer Lett. 42:23–28.
Ibric, L. L., Peterson, A. R., and Sevanian, A., 1991, Mechanisms of ascorbic acid-induced inhibition of chemical transformation in C3H/10T1/2 cells, Am. J. Clin. Nutr. 54:1236S–1240S.
Liehr, J. G., Roy, D., and Gladek, A., 1989, Mechanism of inhibition of estrogen-induced renal carcinogenesis in male Syrian hamsters by vitamin C, Carcinogenesis 10:1983–1988.
McCay, P. B., 1985, Vitamin E: Interactions with free radicals and ascorbate, Ann. Rev. Nutr. 5:323–340.
Moertel, C. G., Fleming, T. R., Creagen, E. T., Rubin, J., O’Connell, J., and Ames, M. M., 1970, High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who had no prior chemotherapy, N. Engl. J. Med. 312:137–141.
Pauling, L., 1970, Evolution and the need for ascorbic acid, Proc. Natl. Acad. Sci. USA 67:1643–1648.
Pauling, L., 1971a, The significance of the evidence about ascorbic acid and the common cold, Proc. Natl. Acad. Sci. USA 68:2678–2681.
Pauling, L., 1971b, Ascorbic acid and the common cold, Am. J. Clin. Nutr. 24:1294–1299.
Pauling, L., 1973, Ascorbic acid and the common cold, Scott Med. J. 18:1–2.
Pauling, L., 1989, Biostatistical analysis of mortality data for cohorts of cancer patients, Proc. Natl. Acad. Sci. USA 86:3466–3488.
Pauling, L., and Herman, Z. S., 1989, Criteria for the validity of clinical trials of treatments of cohorts of cancer patients based on the Hardin Jones principle, Proc. Natl. Acad. Sci. USA 86:6835–6837.
Reed, D. J., 1993, Interaction of vitamin E, ascorbic acid and glutathione in protection against oxidative damage, in Vitamin E in Health and Disease (L. Packer and J. Fuchs, eds.), pp. 269–280. Dekker Press, New York.
Schwartz, J. L., and Shklar, G., The effect of antioxidant micronutrients on cancer cells in culture: Molecular studies, submitted for publication.
Schwartz, J. L., Sloane, D., and Shklar, G., 1989, Prevention and inhibition of oral cancer in the hamster buccal pouch model associated with carotenoid immune enhancement, Tumor Biol. 19:297–309.
Schwartz, J. L., Shklar, G., and Trickier, D. P., 1993, Vitamin C enhances the development of carcinomas in the hamster pouch experimental model, Oral Surg., Oral Med., Oral Pathol. 76:718–722.
Shklar, G., Schwartz, J. L., Trickier, D. P., and Reid, S., 1990, Prevention of experimental cancer and immunostimulation by vitamin E (immunosurveillance), J. Oral Pathol. Med. 19:60–64.
Shklar, G., Schwartz, J. L., Trickier, D. P., and Reid-Cheverie, S., 1993, The effectiveness of a mixture of beta carotene, alpha tocopherol, glutathione, and ascorbic acid for cancer chemoprevention, Nutr. Cancer 20:145–151.
Tauchi, H., and Sawada, S., 1993, Suppression of gamma- and neutron-induced neoplastic transformation by ascorbic acid in Balb/c 3T3 cells, Int. J. Radiat. Biol. 63:369–374.
Trickier, D. P., Shklar, G., and Schwartz, J. L., 1993, Inhibition of oral carcinogenesis by glutathione, Nutr. Cancer 20:139–144.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Penum Press, New York
About this chapter
Cite this chapter
Shklar, G., Schwartz, J.L. (1996). Ascorbic Acid and Cancer. In: Harris, J.R. (eds) Subcellular Biochemistry. Subcellular Biochemistry, vol 25. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0325-1_12
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0325-1_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7998-0
Online ISBN: 978-1-4613-0325-1
eBook Packages: Springer Book Archive